Organization: Health Canada
Year: 2024
Month: August
Request Number: A-2024-000552
Request Summary: Purchase contracts or promises to purchase COVID-19 vaccines from Medicago from March 2020 to February 2023. Agreements to cancel or withdraw the purchase of COVID-19 vaccines from Medicago from March 2020 to August 2024. All documents relating to the number of COVID-19 vaccines preordered from Medicago from March 2020 to February 2023. Dates and terms of delivery of COVID-19 vaccines preordered from Medicago from March 2020 to February 2023. All documents relating to the number of COVID-19 vaccines preordered from Medicago from March 2020 to February 2023. Terms of payment for doses of COVID-19 vaccines preordered from Medicago from March 2020 to February 2023. Terms and conditions for cancellation or withdrawal of the purchase of COVID-19 vaccines from Medicago from March 2020 to August 2024. Terms and conditions for reimbursement by Medicago of amounts received for the purchase or prepurchase of preordered COVID-19 vaccines from Medicago from March 2020 to August 2024. Investment, partnership or support contracts for the development of COVID-19 vaccines by Medicago and for clinical trials for March 2020 to February 2023. Investment, partnership or support agreements for the development of COVID-19 vaccines by Medicago and for clinical trials from March 2020 to August 2024. Any document concerning: Amount payable to Medicago for investment, partnership or support for the development of COVID-19 vaccines and for clinical trials between March 2020 to February 2023. Terms for payment of investment, partnership or support to Medicago for the development of COVID-19 vaccines by Medicago and for clinical trials between March 2020 to February 2023. Terms and conditions for cancellation or withdrawal of investment, partnership or support to Medicago for the development of COVID-19 vaccines and for clinical trials between March 2020 to August 2024. Terms and conditions for repayment by Medicago of amounts received for investment, partnership or support for the development of COVID-19 vaccines and for clinical trials between March 2020 to August 2024.
Disposition: No records exist
Number of pages: 0